The Tempe, Arizona–based specialty distributor BioCareSD announced that Altuviiio [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl], previously referred to as efanesoctocog alfa, is now available through its network. It is indicated for routine prophylaxis and on-demand treatment to control bleeding episodes, as well as perioperative management for adults and children with hemophilia A.
APRIL 13, 2023